<p>Within
the span of a few months, the severe acute respiratory syndrome coronavirus,
COVID-19 (SARS-CoV-2), has proven to be a pandemic, affecting the world at an
exponential rate. It is extremely pathogenic and causes communicable infection
in humans. Viral infection causes difficulties in breathing, sore throat,
cough, high fever, muscle pain, diarrhea, dyspnea, and may lead to death.
Finding a proper drug and vaccines against this virus is the need of the hour. The
RNA genome of COVID19 codes for the main protease M<sup>pro</sup>, which is
required for viral multiplication. To identify possible antiviral drug(s), we
performed molecular docking studies. Our screen identified ten biomolecules
naturally present in <i>Aspergillus flavus</i> and <i>Aspergillus oryzae</i>
fungi. These molecules include Aspirochlorine, Aflatoxin B1,
Alpha-Cyclopiazonic acid, Sporogen, Asperfuran, Aspergillomarasmine A,
Maltoryzine, Kojic acid, Aflatrem and Ethyl 3-nitropropionic acid, arranged in
the descending order of their docking score. Aspirochlorine exhibited the
docking score of – 7.18 Kcal/mole, higher than presently used drug Chloroquine (-6.2930522 Kcal/mol) and out of ten ligands
studied four has docking score higher than chloroquine. These natural bioactive
compounds could be tested for their ability to inhibit viral growth <i>in- vitro</i> and <i>in-vivo</i>.<b> </b></p>